Objective： To analyze the immunological characteristics of 2,4,6-trinitrobenzene sulfonic acid（TNBS）-induced colitis model and examine the therapeutic effects and mechanisms of Astragalus polysaccharides（APS） tre...Objective： To analyze the immunological characteristics of 2,4,6-trinitrobenzene sulfonic acid（TNBS）-induced colitis model and examine the therapeutic effects and mechanisms of Astragalus polysaccharides（APS） treatment. Methods： Thirty-two male specific pathogen free Spragne-Dawley rats were randomly equally assigned to four groups： control, TNBS, APS and prednisone groups. Experimental colitis was induced by enema administration of TNBS. Then rats were treated with APS（0.5 g·kg^（-1）·day^（-1）, once daily） or prednisone（1.0 mg·kg^（-1）·day^（-1）, once daily） by gavage for 14 days. Macroscopic lesion and histological damage were determined, and activity of myeloperoxidase（MPO） was measured in the colonic tissues. Expressions of T-box expressed in T-cells（T-bet） and GATA-binding protein-3（GATA-3） were determined by immunohistochemistry analysis and western blot. Results： Both macroscopic lesion and histological colonic damage induced by TNBS were reduced by APS and prednisone treatment. These were accompanied by significant attenuation of MPO activity（P=0.03）. TNBS intervention enhanced the expression of both GATA-3 and T-bet, but the expression of T-bet was significantly enhanced than that of GATA-3, resulting in significant reduction of GATA-3/T-bet ratio（P=0.025）. APS administration enhanced the expression of T-bet（P=0.04） and GATA-3（P=0.019） in comparison to TNBS group, and resulting in an up-regulated GATA-3/T-bet ratio. Prednisone treatment inhibited both expressions; however it also resulted in up-regulation of the GATA-3/T-bet ratio. Conclusions： These results demonstrated that APS exerted a beneficial immune regulatory effect on experimental colitis. It promoted the expression of T helper cell 1（Th1） and T helper cell 2（Th2） specific transcription factors but ultimately favor a shift toward Th2 phenotype, suggesting that APS possessed therapeutic potential in experimental colitis.展开更多
基金Supported by Doctoral Fund of Ministry of Education of China
文摘Objective： To analyze the immunological characteristics of 2,4,6-trinitrobenzene sulfonic acid（TNBS）-induced colitis model and examine the therapeutic effects and mechanisms of Astragalus polysaccharides（APS） treatment. Methods： Thirty-two male specific pathogen free Spragne-Dawley rats were randomly equally assigned to four groups： control, TNBS, APS and prednisone groups. Experimental colitis was induced by enema administration of TNBS. Then rats were treated with APS（0.5 g·kg^（-1）·day^（-1）, once daily） or prednisone（1.0 mg·kg^（-1）·day^（-1）, once daily） by gavage for 14 days. Macroscopic lesion and histological damage were determined, and activity of myeloperoxidase（MPO） was measured in the colonic tissues. Expressions of T-box expressed in T-cells（T-bet） and GATA-binding protein-3（GATA-3） were determined by immunohistochemistry analysis and western blot. Results： Both macroscopic lesion and histological colonic damage induced by TNBS were reduced by APS and prednisone treatment. These were accompanied by significant attenuation of MPO activity（P=0.03）. TNBS intervention enhanced the expression of both GATA-3 and T-bet, but the expression of T-bet was significantly enhanced than that of GATA-3, resulting in significant reduction of GATA-3/T-bet ratio（P=0.025）. APS administration enhanced the expression of T-bet（P=0.04） and GATA-3（P=0.019） in comparison to TNBS group, and resulting in an up-regulated GATA-3/T-bet ratio. Prednisone treatment inhibited both expressions; however it also resulted in up-regulation of the GATA-3/T-bet ratio. Conclusions： These results demonstrated that APS exerted a beneficial immune regulatory effect on experimental colitis. It promoted the expression of T helper cell 1（Th1） and T helper cell 2（Th2） specific transcription factors but ultimately favor a shift toward Th2 phenotype, suggesting that APS possessed therapeutic potential in experimental colitis.
